| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $158K | +36.6% |
| Cost of Revenue | $102K | +75.8% |
| Gross Profit | $55K | -3.3% |
| R&D Expense | $10K | — |
| SG&A Expense | $161K | +59.6% |
| Operating Income | -$116K | -166.3% |
| Net Income | -$98K | -134.5% |
| EPS (Basic) | -$0.01 | -125.0% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $266K | -7.3% |
| Accounts Receivable | $48K | +17.5% |
| Current Assets | $323K | -4.1% |
| Total Assets | $323K | -4.1% |
| Current Liabilities | $426K | +26.1% |
| Total Liabilities | $426K | +26.1% |
| Stockholders' Equity | -$103K | -8910.0% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3K | +95.5% |
| Financing Cash Flow | -$14K | -104.6% |